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Abstract
Background: Assessment of left main stem (LMS) stenosis has prognostic and therapeutic implications. Data on
assessment of LMS disease by cardiovascular magnetic resonance (CMR) and single photon emission computed
tomography (SPECT) are limited. CE-MARC is the largest prospective comparison of CMR and SPECT against quantitative
invasive coronary angiography (QCA) for detection of coronary artery disease (CAD), and provided the framework for this
evaluation. The aims of this study were to compare diagnostic accuracy of visual and quantitative perfusion
CMR to SPECT in patients with LMS stable CAD.
Methods: Fifty-four patients from the CE-MARC study were included: 27 (4%) with significant LMS or LMS-equivalent
disease on QCA, and 27 age/sex-matched patients with no flow-limiting CAD. All patients underwent multi-parametric
CMR, SPECT and QCA. Performance of visual and quantitative perfusion CMR by Fermi-constrained deconvolution to
detect LMS disease was compared with SPECT.
Results: Of 27 patients in the LMS group, 22 (81%) had abnormal CMR and 16 (59%) had abnormal SPECT. All patients
with abnormal CMR had abnormal perfusion by visual analysis. CMR demonstrated significantly higher area under the
curve (AUC) for detection of disease (0.95; 0.85–0.99) over SPECT (0.63; 0.49–0.76) (p = 0.0001). Global mean stress
myocardial blood flow (MBF) by CMR in LMS patients was significantly lower than controls (1.77 ± 0.72 ml/g/min
vs. 3.28 ± 1.20 ml/g/min, p < 0.001). MBF of <2.08 ml/g/min had sensitivity of 78% and specificity of 85% for diagnosis of
LMS disease, with an AUC (0.87; 0.75–0.94) not significantly different to visual CMR analysis (p = 0.18), and more accurate
than SPECT (p = 0.003).
Conclusion: Visual stress perfusion CMR had higher diagnostic accuracy than SPECT to detect LMS disease. Quantitative
perfusion CMR had similar performance to visual CMR perfusion analysis.
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Background
Left main stem (LMS) coronary artery disease (CAD) is
found in approximately 5% of patients with stable angina
and in approximately 7% of patients presenting with an
acute myocardial infarction [1]. Significant LMS disease
is typically defined as a stenosis of ≥50% and LMS equiva-
lent as ≥70% stenosis of both the proximal left anterior
descending artery (LAD) and proximal circumflex artery
(LCx). Significant LMS disease is associated with poor
clinical outcomes, with an untreated 3-year survival of
50% in those with >50% stenosis dropping to 41% in those
with stenosis >70% [2, 3]. Several studies have demon-
strated survival benefit for revascularisation of significant
LMS stenosis [4, 5]. Thus, accurate detection and func-
tional assessment of the degree of LMS stenosis has both
important prognostic and therapeutic implications.
Patients evaluated for suspected CAD frequently undergo
functional imaging, which may include single-photon emis-
sion computed tomography (SPECT) or cardiovascular
magnetic resonance (CMR) imaging. A normal myocar-
dial perfusion study by either of these techniques is as-
sociated with an excellent long-term prognosis [6–8].
Published data on the utility of SPECT for the diagnosis
of LMS disease are limited, with variable diagnostic accur-
acy reported [9–12]. Equally, the diagnostic accuracy of
stress perfusion CMR is poorly established in LMS disease.
The Clinical Evaluation of MAgnetic Resonance imaging
in Coronary heart disease (CE-MARC) study [13, 14] was
a large prospective study of patients with suspected CAD;
752 patients were enrolled and all were scheduled to
undergo CMR, SPECT and the reference standard invasive
coronary angiography. Using the CE-MARC dataset, we
hypothesised that CMR would have a greater diagnostic
accuracy than SPECT for the detection of LMS or LMS
equivalent CAD, and that quantitative CMR perfusion
analysis would improve diagnostic discrimination com-
pared to visual analysis.
Methods
Subjects
All patients with LMS disease ≥50%, and left main equiva-
lent (≥70% stenosis of proximal LAD and LCx arteries) by
quantitative coronary angiography (QCA) were selected
from the CE-MARC population, together with an equal
number of control patients without significant stenosis on
X-ray angiography. The control patients were independ-
ently matched to the LMS group for age, sex and cardiovas-
cular risk factors. The inclusion criteria and full imaging
protocol for CE-MARC have been previously reported [14].
In brief, inclusion criteria were: stable chest pain thought to
be angina pectoris, at least one cardiovascular disease risk
factor, suitability for coronary revascularisation if required
and in sinus rhythm. Exclusion criteria were: previous cor-
onary artery bypass surgery, evidence of crescendo angina
or acute coronary syndrome, contraindication to CMR
imaging or adenosine infusion, and chronic renal fail-
ure. The study was performed in accordance with the Dec-
laration of Helsinki (October 2000), with all patients
providing informed written consent. The study protocol
and other relevant documentation had been approved by
the National Research Ethics Committee.
CMR protocol
Patients underwent perfusion-CMR on a 1.5 T scanner
(Philips Medical Systems, Best, The Netherlands) equipped
with “Master” gradients (30 mT/m peak gradient, 150 mT/
m/ms slew rate) and a five-element cardiac phased-array
receiver coil. Stress perfusion imaging was performed using
intravenous adenosine (140mcg/kg/min) infused for 4 min.
Perfusion imaging was performed every heartbeat during
the first-pass in 3 short-axis imaging planes, representing
the basal, midventricular, and apical myocardial segments.
Images were acquired by using a T1-weighted satur-
ation recovery turbo field-echo imaging sequence, using
a shared (non–slice-selective) saturation pulse. A bolus
of 0.05 mmol/kg gadopentetate dimeglumine [Gd-DTPA],
(Magnevist, Bayer Schering Health Care Limited, UK)
followed by a 15 ml saline flush was administered at 5 ml/s
into an antecubital vein by a power injector (Medrad
Spectris Solaris, Medrad Inc., Warrendale, Pennsylvania,
USA). Resting myocardial perfusion was then assessed and
the data obtained with identical parameters as for the rest-
ing perfusion acquisition. The CMR protocol also included
cine imaging for assessment of left ventricular (LV) func-
tion and late gadolinium enhancement imaging (LGE) [14].
SPECT protocol
SPECT radionuclide imaging was carried out on a dedicated
cardiac gamma camera (MEDISO Cardio-C, Budapest,
Hungary), using a two-day scanning protocol, the radioiso-
tope tracer 99mTc tetrofosmin (Myoview), with a stand-
ard dose of 400 MBq, weight-adjusted to a maximum of
600 MBq, per examination. Stress and rest ECG-gated
SPECT images were acquired. The stress imaging protocol
was performed using intravenous adenosine (140mcg/kg/
min) for 4 min followed by isotope injection to minimise
variation between SPECTand CMR [14].
X-ray angiography
All patients underwent invasive X-ray coronary angiography
by a cardiologist (blinded to SPECTand CMR results).
CMR analysis
The methods for the visual analysis of CMR in CE-MARC
have been described previously [14]. As per the original
analysis, CMR was deemed positive if one or more abnor-
mality of perfusion, wall motion abnormality or scar was
present [13, 14].
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For quantitative perfusion analysis, perfusion CMR data
were exported in DICOM format and post-processed off-
line using the software cvi42, (version 5.1.0, Circle Cardio-
vascular Imaging, Calgary, Alberta, Cananda.) Contours
depicting the myocardium and a region within the LV
blood pool were drawn manually (Fig. 1). These contours
were copied to all time frames and manually adjusted for
breathing motion by using rigid translation. The myocar-
dium was subdivided into six circumferentially equidistant
regions in the basal and middle sections and four in the
apical section according to the standard American
Heart Association (AHA) model [15].
Quantitative perfusion parameters were calculated using
in-house software written in Matlab (Mathworks, Natick,
Massachusetts, USA) [16]. Myocardial blood flow (MBF)
was estimated using Fermi-constrained deconvolution
[17]. Blood pool and myocardial curves were converted to
contrast agent concentrations assuming a linear relation-
ship between signal intensity and concentration as previ-
ously described [16]. An assumed native blood T1 value of
1435 ms and a contrast agent relaxivity of 4.3 s−1·mM−1
was used. The arterial input function was taken from the
basal slice (which had the shortest preparation delay).
Concentration curves were baseline subtracted, corrected
for temporal shifts between the arterial input function and
the myocardial curves and limited to the first pass of con-
trast through the left ventricle using previously described
automated methods [16, 18]. Myocardial perfusion reserve
(MPR) was calculated as the ratio of stress MBF to rest
MBF. Segmental MBF and MPR were averaged to produce
per-patient indices for statistical analysis. This was per-
formed with 16 segments to give a global myocardial
value, and separately for segments in the LMS territory.
The LMS territory comprised segments 1, 2, 5–8, 11–14
and 16 [15]. A quantitative SSS was produced by applying
the optimal MBF value derived by Youden’s index (as
detailed in the statistical methods) to the MBF generated
in each of the 16 segments for each patient.
X-ray angiography analysis
X-ray angiography images were analysed by two cardiolo-
gists experienced in invasive coronary angiography. QCA
analysis was performed off-line using QCAPlus software
(Sanders Data Systems, Palo Alto, California, USA). For
all LMS patients, visual and quantitative analysis of the
invasive angiogram were concordant.
SPECT analysis
SPECT data sets were analysed in a blinded manner,
simultaneously by a cardiologist with >10 years’ experi-
ence in nuclear cardiology and an experienced medical
physicist. Evidence of ischaemia by visual comparison of
rest/stress perfusion scans, based on the standard 17-
segment AHA model, was performed. Additionally, evi-
dence of ischaemia by semi-quantitative scoring (using the
QPS 20 segment) (QPS, Cedars-Sinai Medical Center,
Los Angeles, California, USA) was also performed. Non-
perfusion markers of significant CAD, such as transient
LV dilatation (TID) and increased right ventricular uptake
were also taken in to consideration as felt appropriate by
the reporting team.
Data analysis and statistics
Statistical analysis was performed using commercially
available software (SPSS, version 22.0, International Busi-
ness Machines, Armonk, New York, USA). Two-sided p
values ≤0.05 were considered to be statistically significant.
Data were compared using Student’s t-test for continuous
Fig. 1 Image panel showing angiography and CMR perfusion of patient with left main stem (LMS) disease. Panel a shows angiography with a
critical distal LMS lesion. The corresponding mid-slice CMR stress perfusion (b) demonstrates a perfusion defect in septum, anterior and lateral
wall. Myocardial curves (c) of the same mid ventricular slice demonstrates hypoperfusion in the segments subtended by the LMS. Orange and
red lines represent the inferior and infero-lateral segments respectively and show higher signal intensity corresponding with no hypoperfusion
in these segments
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variables and Fisher’s Exact test for proportions, inde-
pendent samples t tests and Pearson’s correlation coef-
ficients as necessary. Normality for MBF values in the
normal comparison group was evaluated using a Q-Q
plot and Shapiro-Wilk test. Receiver operating charac-
teristic (ROC) curve analysis for diagnostic tests were
compared using the method described by DeLong et al.
[19]. For quantitative perfusion analysis, the optimal
sensitivity and specificity of quantitative parameters
were derived by calculating Youden’s index [20]. The
sensitivity and specificity and ROC analysis were based
on the 54 patients.
Results
Visual analysis
Twenty-seven (4%) patients of the 729 patients that re-
ceived invasive angiography from CE-MARC were identi-
fied to have LMS or LMS equivalent disease by invasive
angiography. Twenty-two patients had true LMS disease
and 5 patients had LMS equivalent disease. Patient char-
acteristics are shown in Table 1.
All patients had completed CMR, SPECT and angiog-
raphy studies. Detection rates for CAD by both CMR
and SPECT are shown in Table 2. Multi-parametric
CMR detected evidence of CAD in a non-significantly
higher proportion of patients with LMS disease than
SPECT (81% vs. 59%, p = 0.14). All patients with abnor-
mal multi-parametric CMR also had abnormal perfusion
CMR by visual analysis. One patient was deemed a false
negative by SPECT that had 1 segment of inferior is-
chaemia. For CMR, the average SSS for LMS patients
was 13.0 ± 9.5, and for controls 0.67 ± 1.0 (p < 0.001).
For SPECT, the average SSS for LMS patients was
5.15 ± 6.5, and for controls 1.93 ± 2.3 (p = 0.02). ROC
analysis demonstrated a significantly higher area under
the curve (AUC) for detection of LMS disease by visual
CMR analysis compared to SPECT (0.95 vs. 0.63;
p = 0.0001, Fig. 2).
Quantitative CMR perfusion analysis
Table 3 shows the results of the quantitative CMR perfu-
sion analysis. Mean stress MBF and mean MPR were
both significantly lower in LMS patients compared to
controls (p < 0.001); resting MBF was similar between
the LMS and control groups (p = 0.14).
ROC analysis (Fig. 3) demonstrated the highest AUC
(0.88) for global MBF as an association with LMS dis-
ease. Global MBF of <2.08 ml/g/min was associated with
a sensitivity of 78% and specificity of 85% for diagnosis
of significant LMS disease. A quantitative SSS was pro-
duced using this value; this score had an AUC not sig-
nificantly different to CMR visual analysis (p = 0.18),
and more accurate than SPECT (p = 0.003, Fig. 4).
Table 4 shows sensitivity, specificity and predictive values
for overall visual analysis by multi-parametric CMR and
SPECT, and quantitative analysis by CMR global MBF.
Discussion
This exploratory analysis of the CE-MARC study has dem-
onstrated the diagnostic accuracy of CMR and SPECT in
the setting of LMS (or equivalent) CAD. The main finding
is that in patients with stable suspected CAD, CMR first-
pass perfusion imaging as part of a multi-parametric proto-
col more accurately detected evidence of CAD in LMS
patients than SPECT. Additionally, quantitative CMR
Table 1 Patient characteristics
Patient characteristic LMS Controls P
N 27 27
Age (years) 65 ± 7 64 ± 6 0.45
Male 23 (85%) 23 (85%) 1.0
Body mass index (kg/m2) 27.5 ± 3.89 27.0 ± 2.87 0.60
Current smoker 5 (19%) 4 (15%) 1.0
Blood pressure (mmHg) 134/74 ± 20/10 140/76 ± 19/7 0.27/0.43
Hypertension 12 (44%) 17 (62%) 0.27
Total cholesterol (mmol/L) 5.3 ± 1.4 4.8 ± 1.2 0.25
Diabetes mellitus 5 (19%) 5 (19%) 1.0
Family history of CADa 14 (52%) 13 (48%) 1.0
Significant CADa
- LMS 22 (81%) 0 (0%) <0.001
- LAD 17 (63%) 0 (0%) <0.001
- LCx 11 (41%) 0 (0%) <0.001
- RCA 11 (41%) 0 (0%) <0.001
Data as mean ± SD or n (%)
aCAD coronary artery disease, LAD left anterior descending coronary artery, LCx
left circumflex coronary artery, RCA right coronary artery
Table 2 Imaging findings
Imaging finding LMS Control P
CMR
- RWMAa positive 17 (63%) 0 (0%) <0.001
- FPP positive 22 (81%) 1 (4%) <0.001
- LGE positive 15 (56%) 0 (0%) <0.001
- Overall positive 22 (81%) 1 (4%) <0.001
SPECT
- RWMA positive 10 (37%) 6 (22%) 0.37
- Fixed defect 6 (22%) 5 (19%) 1.0
- Inducible defect 17 (63%) 4 (15%) <0.001
- TID 1 (4%) 1 (4%) 1.0
- RV uptake 17 (63%) 14 (52%) 0.58
- Overall positive 16 (59%) 3 (11%) <0.001
Data as n (%)
aRWMA regional wall motion abnormality, FPP first pass perfusion, LGE late
gadolinium enhancement, TID left ventricular transient ischaemic dilatation,
RV right ventricular isotope uptake
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perfusion showed high diagnostic accuracy for the detec-
tion of LMS disease with global MBF as the most diagnos-
tic, however quantitative perfusion did not outperform
visual CMR perfusion analysis.
CMR is established as a cost effective investigation
with high diagnostic accuracy compared to SPECT for
the diagnosis of suspected CAD [13, 21–23]. Previous
data on the diagnostic accuracy of SPECT and CMR in
LMS disease are sparse. Thus far there are no studies
specifically investigating the diagnostic accuracy of CMR
for LMS disease. The MR-IMPACT study [24], a multi-
centre comparison of CMR and SPECT in 234 patients,
included eight patients with LMS disease, while MR-
IMPACT II analysed 465 patients of which 14 had LMS
disease [22]; in neither of these studies were patients
with LMS disease separately analysed. The majority of
studies validating CMR perfusion techniques have less
than five LMS patients, effectively precluding meaning-
ful analysis of this subset. In contrast, the CE-MARC
study had a LMS population of sufficient size to allow
reasonable conclusions to be drawn [13]. SPECT studies
of LMS disease have largely been un-blinded,
retrospective and derived from angiographic databases
[9–11]; in this context referral bias potentially leads to
an over-estimation of the sensitivity of SPECT for the
detection of LMS disease [10], as the false negative
SPECT scans go unevaluated.
Non-invasive detection of CAD is clinically useful to
both determine the presence of clinically significant
disease and to estimate the severity and extent of disease.
The classical finding of an inducible perfusion abnormality
involving both the LAD and LCx coronary artery territories
was not robustly seen in LMS patients by either CMR or
SPECT. This perfusion defect pattern has been described
with varying frequency from 12 to 59% of SPECT patients
with documented significant LMS stenosis in retrospective
analyses [9, 11, 12]. This perfusion defect pattern was seen
in just 8 LMS patients (30%) by CMR and 2 patients (7%)
by SPECT in our study. The low diagnostic yield specific
for LMS disease may be due, in part, to distal and bifur-
cation LMS lesions, which may have a differential effect on
myocardial perfusion to the LAD and LCx territories,
resulting in underestimation of LMS disease. Furthermore,
although a visual or QCA reported stenosis of 50% of the
LMS is deemed significant by convention, not all 50% cor-
onary stenoses are haemodynamically significant when
assessed by invasive fractional flow reserve (FFR) [25]. In
addition, a myocardial perfusion abnormality consistent
with LMS disease may be less apparent in the presence of
coronary collateralisation, or flow-limiting stenosis in the
right coronary artery (i.e. 3-vessel disease). However, these
haemodynamic factors do not account for the differential
detection rates of CMR and SPECT (overall 81% vs. 59%
for detection of CAD). The phenomenon of “balanced
ischaemia” in multivessel disease potentially leads to an
underestimation of disease, in SPECT this effect is reported
Fig. 2 ROC curves for visual summed stress scores for CMR and single photon emission computed tomography (SPECT). Numbers in parentheses
indicates area under the curve (AUC) with 95% confidence intervals
Table 3 Quantitative CMR perfusion analysis
LMS Control P-value
Global stress MBF 1.77 ± 0.72 3.28 ± 1.20 <0.001
Global rest MBF 1.28 ± 0.42 1.48 ± 0.55 0.14
Global MPR 1.42 ± 0.44 2.31 ± 0.76 <0.001
LMS territory stress MBF 2.03 ± 0.77 3.38 ± 1.15 <0.001
LMS territory rest MBF 1.42 ± 0.36 1.54 ± 0.56 0.36
LMS territory MPR 1.53 ± 0.44 2.34 ± 0.64 <0.001
MBF values are in ml/g/min
MBF myocardial blood flow, MPR myocardial perfusion reserve
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with variable frequency [26, 27]. In this context, CMR has
been shown to have an advantage over SPECT to detect
perfusion defects (in multivessel disease) due to a higher
spatial resolution [28, 29]. Furthermore, multi-vessel dis-
ease has been shown to not be significantly associated with
false negatives in CMR [30].
Wide interobserver variability for visual severity of
stenoses of the LMS have been reported [31, 32]. In our
study QCA was used to determine the severity of angio-
graphic stenoses, as per the CE-MARC study protocol
[13, 14]. In this context, there is a potential limitation of
the invasive reference standard; however FFR and intra-
vascular ultrasound are only recommended as adjuncts
in LMS disease assessment in current guidelines and
revascularisation decisions are, for the mainstay, based
on severity of angiographic stenosis [33, 34].
Additional diagnostic aids have been proposed to
improve the sensitivity of SPECT for the diagnosis of
LMS disease. TID of the left ventricular cavity in
response to stress has been identified to be a strong
predictor of cardiac events [35], reflecting global sub-
endocardial ischaemia or stress-induced left ventricu-
lar dysfunction from left main or three vessel disease
[36]. Increased right ventricular radiotracer uptake
has also been independently associated with LMS dis-
ease, with a 60% increase from 0.33 ± 0.07 at rest to
0.51 ± 0.07 with stress in LMS patients (p < 0.001
compared to controls) [37, 38]. When non-perfusion
markers of widespread ischaemia are used alongside
perfusion data, the proportion of patients with LMS
stenosis identified by SPECT increased from 56 to
83% in one study [9]. In our population, however
TID was seen less frequently, with no significant dif-
ference in right ventricular uptake between LMS pa-
tients and controls suggesting limited discriminatory
value. These markers were used for SPECT analysis in
this study, but to date have not been used as standard
in CMR, and were not prospectively evaluated here.
Fig. 3 ROC curves for CMR quantitative perfusion results. Numbers in parentheses indicates AUC with 95% confidence intervals
Fig. 4 ROC curves for quantitative summed stress score for MBF, visual CMR and SPECT. Numbers in parentheses indicates AUC with 95%
confidence intervals
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This study also examined the utility of quantitative
CMR perfusion as a potential approach to account for
balanced myocardial hypoperfusion that theoretically
limits visual analysis in LMS or 3-vessel disease. Other
studies have shown that quantitative estimation of myo-
cardial perfusion reserve by CMR over visual analysis
improved sensitivity from 74 to 88% and specificity from
58 to 90% for patients suspected to have coronary artery
disease, but not confined to LMS [39]. The Fermi decon-
volution method used in our study has been shown to
perform as well as any other model for the detection of
CAD [16]. Patel et al. identified increased ischaemia
burden by quantitative perfusion methods using Fermi
deconvolution over qualitative assessment as severity of
coronary disease increased in patients undergoing perfu-
sion CMR with multi-vessel disease [40]. The value of
quantitative CMR analysis for LMS lesions has not been
previously detailed. In our study, global MBF was the
best quantitative marker and showed high sensitivity and
specificity (78 and 85% respectively) for the diagnosis of
LMS disease. Quantitative perfusion analysis however
was not significantly better than visual CMR perfusion
analysis, suggesting that visual perfusion analysis is suffi-
cient to detect heterogeneities in myocardial contrast
distribution in LMS disease, a finding supported by dedi-
cated analysis of false-negative CMR [30]. Furthermore,
our results suggest there is little additive value to be
gained from the quantification of rest perfusion when
quantitation of stress perfusion is performed.
Limitations
Given the low prevalence of LMS disease, the numbers
in this prospective study are limited. In our study SPECT
analysis did not use attenuation correction; however this
was not routine practice when the study was performed
[41]. We did not use FFR as our invasive reference stand-
ard, however we did use QCA in line with the main CE-
MARC paper. The pulse sequence used for perfusion
imaging in CE-MARC was not fully optimised for quanti-
tative analysis as it used a single preparation pulse for all
three slices and a relatively high contrast agent dose. This
may have led to a lower performance of quantitative ana-
lysis in this study compared to recent approaches. The
lack of a completely linear arterial input function
measurement for MBF analysis, with the assumption that
concentration is linearly related to signal intensity will re-
sult in an overestimate of absolute myocardial blood flow.
However, post-hoc correction based on baseline signal
intensity values would introduce noise into the mea-
surements that could reduce diagnostic accuracy [42].
Furthermore, studies comparing dual-bolus and uncor-
rected single bolus myocardial blood flow estimates have
not shown significant differences in diagnostic accuracy
[43]. Our diagnostic accuracy values agree well with other
studies in the literature, suggesting that these limitations
have not significantly impacted on our findings.
Conclusion
This study shows that visual stress perfusion CMR had
higher diagnostic accuracy than SPECT to detect signifi-
cant LMS or LMS equivalent disease. Quantitative per-
fusion CMR by Fermi-constrained deconvolution had
similar performance to visual CMR perfusion analysis.
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